Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
Cardiovasc Res
    November 2024
  1. BODI I, Mettke L, Michaelides K, Hornyik T, et al
    Beneficial normalization of cardiac repolarization by carnitine in transgenic short QT syndrome type 1 rabbit models.
    Cardiovasc Res. 2024;120:1550-1561.
    >> Share

    October 2024
  2. LI X, Bao Y, Zhang N, Lin C, et al
    Senescent CD8+ T cells: a novel risk factor in atrial fibrillation.
    Cardiovasc Res. 2024 Oct 9:cvae222. doi: 10.1093.
    >> Share

    September 2024
  3. LI N, Cui L, Korantzopoulos P, Zhang N, et al
    Association between cumulative uric acid exposure and the risk of incident cardiac conduction block.
    Cardiovasc Res. 2024;120:1104-1106.
    >> Share

  4. FAKIH W, Mroueh A, Gong DS, Kikuchi S, et al
    Activated factor X stimulates atrial endothelial cells and tissues to promote remodelling responses through AT1R/NADPH oxidases/SGLT1/2.
    Cardiovasc Res. 2024;120:1138-1154.
    >> Share

    July 2024
  5. COLEMAN JA, Doste R, Ashkir Z, Coppini R, et al
    Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.
    Cardiovasc Res. 2024;120:914-926.
    >> Share

    May 2024
  6. LIUTKUTE A, Prosser BL, Voigt N
    Microtubules: highway to ... arrhythmia?
    Cardiovasc Res. 2024;120:671-672.
    >> Share

  7. ODENING KE
    Interactions between KCNQ1 and KCNH2 may modulate the long QT type 1 phenotype.
    Cardiovasc Res. 2024;120:673-674.
    >> Share

  8. WADA Y, Wang L, Hall LD, Yang T, et al
    The electrophysiologic effects of KCNQ1 extend beyond expression of IKs: evidence from genetic and pharmacologic block.
    Cardiovasc Res. 2024;120:735-744.
    >> Share

  9. PAVLAKI N, Froese A, Li W, De Jong KA, et al
    Gene therapy with phosphodiesterases 2A and 4B ameliorates heart failure and arrhythmias by improving subcellular cAMP compartmentation.
    Cardiovasc Res. 2024 May 22:cvae094. doi: 10.1093.
    >> Share

  10. KEEFE JA, Zhao S, Wehrens XHT
    A mechanistic LNK between inflammation and atrial fibrillation?
    Cardiovasc Res. 2024 May 7:cvae083. doi: 10.1093.
    >> Share

    April 2024
  11. MEHDIZADEH M, Naud P, Abu-Taha IH, Hiram R, et al
    The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology.
    Cardiovasc Res. 2024;120:506-518.
    >> Share

  12. KAHNERT K, Soattin L, Mills RW, Wilson C, et al
    Proteomics couples electrical remodelling to inflammation in a murine model of heart failure with sinus node dysfunction.
    Cardiovasc Res. 2024 Apr 25:cvae054. doi: 10.1093.
    >> Share

  13. FABRITZ L, Chua W, Cardoso VR, Al-Taie C, et al
    Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study.
    Cardiovasc Res. 2024 Apr 13:cvae067. doi: 10.1093.
    >> Share

    March 2024
  14. DE COSTER T, Teplenin AS, Feola I, Bart CI, et al
    'Trapped re-entry' as source of acute focal atrial arrhythmias.
    Cardiovasc Res. 2024;120:249-261.
    >> Share

  15. TONKO JB, Lambiase PD
    The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies.
    Cardiovasc Res. 2024;120:114-131.
    >> Share

    February 2024
  16. KIZER JR
    The elusive quest for causality in adiponectin's bimodal relationship with cardiovascular disease: Mendelian randomization meets Janus.
    Cardiovasc Res. 2024;120:3-5.
    >> Share

  17. HARDING D, Fanti S, Marelli-Berg F
    Tumour necrosis factor-alpha in cardiac inflammation: friend or foe?
    Cardiovasc Res. 2024;120:1-2.
    >> Share

  18. HEIJMAN J, Madreiter-Sokolowski CT
    Is ageing a modifiable risk factor for atrial fibrillation?
    Cardiovasc Res. 2024 Feb 26:cvae040. doi: 10.1093.
    >> Share

  19. FABRITZ L, Lemoine MD
    Atrial fibrillation in the young: consider heritable conditions like short QT syndrome.
    Cardiovasc Res. 2024 Feb 22:cvae041. doi: 10.1093.
    >> Share

  20. VELASCO JJ, Akar FG
    A new year's resolution to resolve atrial fibrillation: Resolvin D1 emerges as a powerful target against post-MI atrial remodeling.
    Cardiovasc Res. 2024 Feb 22:cvae039. doi: 10.1093.
    >> Share

  21. MURPHY MB, Yang Z, Subati T, Farber-Eger E, et al
    LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation.
    Cardiovasc Res. 2024 Feb 20:cvae036. doi: 10.1093.
    >> Share

  22. ROGERS AJ, Narayan SM
    Latent drivers for atrial fibrillation and specific patterns of localized fibrosis.
    Cardiovasc Res. 2024 Feb 20:cvae032. doi: 10.1093.
    >> Share

    January 2024
  23. NGUYEN MN, Hooper C, Stefanini M, Vrellaku B, et al
    Why is early-onset atrial fibrillation uncommon in patients with Duchenne Muscular Dystrophy? Insights from the mdx mouse.
    Cardiovasc Res. 2024 Jan 25:cvae022. doi: 10.1093.
    >> Share

  24. MORENO-MANUEL AI, Macias A, Cruz FM, Gutierrez LK, et al
    The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of Short QT Syndrome type 3.
    Cardiovasc Res. 2024 Jan 23:cvae019. doi: 10.1093.
    >> Share

  25. SHI Q, Malik H, Crawford RM, Streeter J, et al
    Cardiac MAO-A inhibition protects against catecholamine-induced ventricular arrhythmias via enhanced diastolic calcium control.
    Cardiovasc Res. 2024 Jan 10:cvae012. doi: 10.1093.
    >> Share

    December 2023
  26. DOREY TW, McRae MD, Belke DD, Rose RA, et al
    PDE4D mediates impaired beta-adrenergic receptor signalling in the sinoatrial node in mice with hypertensive heart disease.
    Cardiovasc Res. 2023;119:2697-2711.
    >> Share

  27. OLCUM M, Fan S, Rouhi L, Cheedipudi S, et al
    Genetic inactivation of beta-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy.
    Cardiovasc Res. 2023;119:2712-2728.
    >> Share

  28. HIRAM R, Xiong F, Naud P, Xiao J, et al
    An inflammation resolution-promoting intervention prevents atrial fibrillation due to left-ventricular dysfunction.
    Cardiovasc Res. 2023 Dec 13:cvad175. doi: 10.1093.
    >> Share

    October 2023
  29. NIELSEN MB, Colak Y, Benn M, Mason A, et al
    Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large scale observational and Mendelian randomization evidence.
    Cardiovasc Res. 2023 Oct 28:cvad162. doi: 10.1093.
    >> Share

  30. NI H, Morotti S, Zhang X, Dobrev D, et al
    Integrative human atrial modelling unravels interactive protein kinase A and Ca2+/calmodulin-dependent protein kinase II signalling as key determinants of atrial arrhythmogenesis.
    Cardiovasc Res. 2023;119:2294-2311.
    >> Share

  31. JONES CA, Wallace MJ, Bandaru P, Woodbury ED, et al
    E-cigarettes and arrhythmogenesis: a comprehensive review of pre-clinical studies and their clinical implications.
    Cardiovasc Res. 2023;119:2157-2164.
    >> Share

    September 2023
  32. VENKATESHAPPA R, Hunter DV, Muralidharan P, Nagalingam RS, et al
    Targeted activation of hERG channels rescues electrical instability induced by the hERG R56Q+/- Long QT Syndrome variant.
    Cardiovasc Res. 2023 Sep 21:cvad155. doi: 10.1093.
    >> Share

  33. LAKIN R, Polidovitch N, Yang S, Parikh M, et al
    Cardiomyocyte and endothelial cells play distinct roles in the tumor necrosis factor (TNF)-dependent atrial responses and increased atrial fibrillation vulnerability induced by endurance exercise training in mice.
    Cardiovasc Res. 2023 Sep 15:cvad144. doi: 10.1093.
    >> Share

  34. SEIBERTZ F, Rubio T, Springer R, Popp F, et al
    Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.
    Cardiovasc Res. 2023 Sep 7:cvad143. doi: 10.1093.
    >> Share

    July 2023
  35. BOURIER F, Schunkert H
    Has genetic disposition implications for treatment decisions in atrial fibrillation?
    Cardiovasc Res. 2023 Jul 5:cvad098. doi: 10.1093.
    >> Share

  36. MARCHAL GA, Galjart N, Portero V, Remme CA, et al
    Microtubule plus-end tracking proteins: novel modulators of cardiac sodium channels and arrhythmogenesis.
    Cardiovasc Res. 2023;119:1461-1479.
    >> Share

    June 2023
  37. KANY S, Al-Taie C, Roselli C, Pirruccello JP, et al
    Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial.
    Cardiovasc Res. 2023 Jun 2:cvad027. doi: 10.1093.
    >> Share

    May 2023
  38. MORENO-MANUEL AI, Gutierrez LK, Vera-Pedrosa ML, Cruz FM, et al
    Molecular stratification of arrhythmogenic mechanisms in the Andersen Tawil syndrome.
    Cardiovasc Res. 2023;119:919-932.
    >> Share

    March 2023
  39. MCKAY M, Akar FG
    A unifying mechanism for the initiation of torsade de pointes: blurring the distinction between trigger and substrate.
    Cardiovasc Res. 2023;119:333-335.
    >> Share

  40. BOOGERD CJ, Lacraz GPA, Vertesy A, van Kampen SJ, et al
    Spatial transcriptomics unveils ZBTB11 as a regulator of cardiomyocyte degeneration in arrhythmogenic cardiomyopathy.
    Cardiovasc Res. 2023;119:477-491.
    >> Share

  41. CAMPOSTRINI G, Kosmidis G, Ward-van Oostwaard D, Davis RP, et al
    Maturation of hiPSC-derived cardiomyocytes promotes adult alternative splicing of SCN5A and reveals changes in sodium current associated with cardiac arrhythmia.
    Cardiovasc Res. 2023;119:167-182.
    >> Share

  42. PARKSOOK WW, Williams GH
    Aldosterone and cardiovascular diseases.
    Cardiovasc Res. 2023;119:28-44.
    >> Share

  43. VARDAS PE
    Large-scale digital population screening for atrial fibrillation: swinging around the uncertainties.
    Cardiovasc Res. 2023 Mar 3:cvad032. doi: 10.1093.
    >> Share

    January 2023
  44. NINNI S, Nattel S
    Factor XIa inhibition in atrial fibrillation: insights and knowledge gaps emerging from the PACIFIC-AF trial.
    Cardiovasc Res. 2023 Jan 25:cvac196. doi: 10.1093.
    >> Share

    December 2022
  45. GIACCA M
    Gene editing for cardiomyopathy takes a step forward.
    Cardiovasc Res. 2022;118:3011-3012.
    >> Share

  46. SUFFEE N, Baptista E, Piquereau J, Ponnaiah M, et al
    Impacts of a high-fat diet on the metabolic profile and the phenotype of atrial myocardium in mice.
    Cardiovasc Res. 2022;118:3126-3139.
    >> Share

    October 2022
  47. TOW BD, Deb A, Neupane S, Patel SM, et al
    SR-Mitochondria Crosstalk Shapes Ca Signalling to Impact Pathophenotype in Disease Models Marked by Dysregulated Intracellular Ca Release.
    Cardiovasc Res. 2022;118:2819-2832.
    >> Share

    July 2022
  48. NYNS ECA, Jin T, Fontes MS, van den Heuvel T, et al
    Optical ventricular cardioversion by local optogenetic targeting and LED implantation in a cardiomyopathic rat model.
    Cardiovasc Res. 2022;118:2293-2303.
    >> Share

  49. KEEFE J, Wehrens XH, Dobrev D
    Common disease-promoting signaling pathways in heart failure and atrial fibrillation: putative underlying mechanisms and potential therapeutic consequences.
    Cardiovasc Res. 2022 Jul 5. pii: 6631397. doi: 10.1093.
    >> Share

    June 2022
  50. CHAUMONT C, Suffee N, Gandjbakhch E, Balse E, et al
    Epicardial origin of cardiac arrhythmias: clinical evidences and pathophysiology.
    Cardiovasc Res. 2022;118:1693-1702.
    >> Share

  51. ALEXANDER C, Bishop MJ, Gilchrist RJ, MRes BA, et al
    Initiation of ventricular arrhythmia in the acquired long QT syndrome.
    Cardiovasc Res. 2022 Jun 21. pii: 6612700. doi: 10.1093.
    >> Share

  52. GAWALKO M, Saljic A, Li N, Abu-Taha I, et al
    Adiposity-associated atrial fibrillation: molecular determinants, mechanisms and clinical significance.
    Cardiovasc Res. 2022 Jun 11. pii: 6605797. doi: 10.1093.
    >> Share

    May 2022
  53. ROUHI L, Fan S, Cheedipudi SM, Braza-Boils A, et al
    The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
    Cardiovasc Res. 2022;118:1466-1478.
    >> Share

    April 2022
  54. LIUTKUTE A, Brundel BJ, Voigt N
    Not the classical serendipity: does doxapram treat atrial fibrillation?
    Cardiovasc Res. 2022 Apr 15. pii: 6568887. doi: 10.1093.
    >> Share

  55. FARINHA JM, Gupta D, Lip GYH
    Frequent premature atrial contractions as a signalling marker of atrial cardiomyopathy, incident atrial fibrillation and stroke.
    Cardiovasc Res. 2022 Apr 7. pii: 6564589. doi: 10.1093.
    >> Share

    March 2022
  56. YU JK, Liang JA, Franceschi WH, Huang Q, et al
    Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.
    Cardiovasc Res. 2022;118:1247-1261.
    >> Share

  57. PROIETTI R, Lip GYH, Akhtar R, Field M, et al
    Thoracic aortic aneurysms and atrial fibrillation: commonality in pathophysiological pathways.
    Cardiovasc Res. 2022;118:e32-e35.
    >> Share

  58. LOUCH WE
    A TRP to the emergency room: Understanding arrhythmia in the ageing heart.
    Cardiovasc Res. 2022;118:932-933.
    >> Share

  59. PEANA D, Polo-Parada L, Domeier TL
    Arrhythmogenesis in the aged heart following ischaemia-reperfusion: role of transient receptor potential vanilloid 4.
    Cardiovasc Res. 2022;118:1126-1137.
    >> Share

    January 2022
  60. MACIAS A, Diaz-Larrosa JJ, Blanco Y, Fanjul V, et al
    Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome.
    Cardiovasc Res. 2022;118:503-516.
    >> Share

  61. BARC J, Ravens U
    Scientists on the Spot: Tracing the potential in electrophysiology.
    Cardiovasc Res. 2022;118:e6-e7.
    >> Share

  62. JAYARAM R, Jones M, Reilly S, Crabtree MJ, et al
    Atrial nitroso-redox balance and refractoriness following on-pump cardiac surgery: a randomized trial of atorvastatin.
    Cardiovasc Res. 2022;118:184-195.
    >> Share

  63. BORIANI G, Vitolo M, Diemberger I, Proietti M, et al
    Publisher's note to: Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes.
    Cardiovasc Res. 2022 Jan 5. pii: 6498023. doi: 10.1093.
    >> Share

    December 2021
  64. RAVENS U, Gomez AM, Heijman J, Remme CA, et al
    Edward Carmeliet (1930-2021)-channelling scientific curiosity: a tribute from the ESC Working Group on Cardiac Cellular Electrophysiologydagger.
    Cardiovasc Res. 2021;117:e171-e173.
    >> Share

  65. COPPINI R, Cerbai E
    Of hits, players, and goalkeepers: the case of arrhythmias in diabetes.
    Cardiovasc Res. 2021;117:2694-2695.
    >> Share

  66. HATEM SN, Cohen A
    Atrial fibrillation and stroke: are we looking in the right direction?
    Cardiovasc Res. 2021 Dec 13. pii: 6460256. doi: 10.1093.
    >> Share

    November 2021
  67. LI N, Durgan DJ, Wehrens XHT
    Gut microbiota - a key regulator of aging-associated atrial fibrillation?
    Cardiovasc Res. 2021 Nov 26. pii: 6443115. doi: 10.1093.
    >> Share

    October 2021
  68. SANTEMA BT, Arita VA, Sama IE, Kloosterman M, et al
    Pathophysiological pathways in patients with heart failure and atrial fibrillation.
    Cardiovasc Res. 2021 Oct 23. pii: 6409189. doi: 10.1093.
    >> Share

  69. NI L, Lahiri SK, Nie J, Pan X, et al
    Genetic inhibition of Nuclear Factor of Activated T-cell c2 (NFATc2) prevents atrial fibrillation in CREM transgenic mice.
    Cardiovasc Res. 2021 Oct 14. pii: 6396865. doi: 10.1093.
    >> Share

    September 2021
  70. DOBREV D, Dudley SC
    Oxidative stress: a bystander or a causal contributor to atrial remodelling and fibrillation?
    Cardiovasc Res. 2021;117:2291-2293.
    >> Share

  71. GAWALKO M, Agbaedeng TA, Saljic A, Muller DN, et al
    Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.
    Cardiovasc Res. 2021 Sep 22. pii: 6373888. doi: 10.1093.
    >> Share

    August 2021
  72. CAMPBELL H, Aguilar-Sanchez Y, Quick AP, Dobrev D, et al
    SPEG: a key regulator of cardiac calcium homeostasis.
    Cardiovasc Res. 2021;117:2175-2185.
    >> Share

  73. BALLOUZ S, Mangala MM, Perry MD, Heitmann S, et al
    Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events.
    Cardiovasc Res. 2021;117:2216-2227.
    >> Share

  74. DING WY, McDowell G, Lip GYH
    Utilising biomarkers in atrial fibrillation: the pros and cons.
    Cardiovasc Res. 2021 Aug 25. pii: 6357701. doi: 10.1093.
    >> Share

  75. POL T, Hijazi Z, Lindback J, Oldgren J, et al
    Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
    Cardiovasc Res. 2021 Aug 6. pii: 6343453. doi: 10.1093.
    >> Share

    July 2021
  76. HALL EJ, Pal S, Glennon MS, Shridhar P, et al
    Cardiac natriuretic peptide deficiency sensitizes the heart to stress induced ventricular arrhythmias via impaired CREB signaling.
    Cardiovasc Res. 2021 Jul 30. pii: 6332002. doi: 10.1093.
    >> Share

  77. AL SAYED ZR, Canac R, Cimarosti B, Bonnard C, et al
    Human model of IRX5 mutations reveals key role for this transcription factor in ventricular conduction.
    Cardiovasc Res. 2021;117:2092-2107.
    >> Share

  78. BOUKENS BJD, Dacey M, Meijborg VMF, Janse MJ, et al
    Mechanism of ventricular premature beats elicited by left stellate ganglion stimulation during acute ischaemia of the anterior left ventricle.
    Cardiovasc Res. 2021;117:2083-2091.
    >> Share

  79. ALVAREZ-FRANCO A, Rouco R, Ramirez RJ, Guerrero-Serna G, et al
    Erratum to: Transcriptome and proteome mapping in the sheep atria reveal molecular features of atrial fibrillation progression.
    Cardiovasc Res. 2021 Jul 13. pii: 6319837. doi: 10.1093.
    >> Share

  80. DERI S, Borbas J, Hartai T, Hategan L, et al
    Impaired cytoplasmic domain interactions cause co-assembly defect and loss of function in the p.Glu293Lys KNCJ2 variant isolated from an Andersen-Tawil syndrome patient.
    Cardiovasc Res. 2021;117:1923-1934.
    >> Share

  81. RATHJENS FS, Blenkle A, Iyer LM, Renger A, et al
    Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control.
    Cardiovasc Res. 2021;117:1908-1922.
    >> Share

  82. ZHAO Y, James NA, Beshay AR, Chang EE, et al
    Adult zebrafish ventricular electrical gradients as tissue mechanisms of ECG patterns under baseline vs. oxidative stress.
    Cardiovasc Res. 2021;117:1891-1907.
    >> Share

    June 2021
  83. SCHOTTEN U
    From translation to integration: how to approach the complexity of atrial fibrillation mechanisms.
    Cardiovasc Res. 2021;117:e88-e90.
    >> Share

  84. SCOTT L JR, Fender AC, Saljic A, Li L, et al
    NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias.
    Cardiovasc Res. 2021;117:1746-1759.
    >> Share

  85. HIRAM R, Xiong F, Naud P, Xiao J, et al
    The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease.
    Cardiovasc Res. 2021;117:1776-1789.
    >> Share

  86. BORIANI G, Vitolo M, Diemberger I, Proietti M, et al
    Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes.
    Cardiovasc Res. 2021;117:1-21.
    >> Share

  87. SANSONETTI M, De Windt LJ
    Non-coding RNAs in cardiac inflammation: key drivers in the pathophysiology of heart failure.
    Cardiovasc Res. 2021 Jun 7. pii: 6294284. doi: 10.1093.
    >> Share

  88. NATTEL S, Lip GYH, Filgueiras-Rama D, Dobrev D, et al
    Challenges and Opportunities in Improving the Management of Atrial Fibrillation: Recent Research Advances and their Clinical Translation.
    Cardiovasc Res. 2021 Jun 4. pii: 6292088. doi: 10.1093.
    >> Share

    May 2021
  89. CASADEI B, Sipido KR
    Calcium and postoperative atrial fibrillation: round up the usual suspects!
    Cardiovasc Res. 2021 May 29. pii: 6288489. doi: 10.1093.
    >> Share

  90. WIEDMANN F, Beyersdorf C, Zhou XB, Kraft M, et al
    Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy.
    Cardiovasc Res. 2021 May 24. pii: 6283579. doi: 10.1093.
    >> Share

  91. HANNA P, Buch E, Stavrakis S, Meyer C, et al
    Neuroscientific Therapies for Atrial Fibrillation.
    Cardiovasc Res. 2021 May 14. pii: 6275748. doi: 10.1093.
    >> Share

  92. KANY S, Reissmann B, Metzner A, Kirchhof P, et al
    Genetics of atrial fibrillation - practical applications for clinical management: If not now, when and how?
    Cardiovasc Res. 2021 May 12. pii: 6274893. doi: 10.1093.
    >> Share

  93. OLIER I, Ortega-Martorell S, Pieroni M, Lip GYH, et al
    How machine learning is impacting research in atrial fibrillation: Implications for risk prediction and future management.
    Cardiovasc Res. 2021 May 12. pii: 6274894. doi: 10.1093.
    >> Share

    April 2021
  94. HEIJMAN J, Sutanto H, Crijns HJGM, Nattel S, et al
    Computational models of atrial fibrillation: achievements, challenges and perspectives for improving clinical care.
    Cardiovasc Res. 2021 Apr 23. pii: 6247759. doi: 10.1093.
    >> Share

  95. HATEM SN
    Revealing the molecular history of the transition from paroxysmal to permanent atrial fibrillation.
    Cardiovasc Res. 2021 Apr 20. pii: 6241493. doi: 10.1093.
    >> Share

    February 2021
  96. PROTONOTARIOS A, Marelli-Berg F
    Influenza-associated cardiac injury: a disease of the cardiac conduction system?
    Cardiovasc Res. 2021;117:643-644.
    >> Share

  97. LEE YK, Sala L, Mura M, Rocchetti M, et al
    MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes.
    Cardiovasc Res. 2021;117:767-779.
    >> Share

    January 2021
  98. HEGYI B, Ko CY, Bossuyt J, Bers DM, et al
    Two-hit mechanism of cardiac arrhythmias in diabetic hyperglycemia: reduced repolarization reserve, neurohormonal stimulation and heart failure exacerbate susceptibility.
    Cardiovasc Res. 2021 Jan 23. pii: 6105172. doi: 10.1093.
    >> Share

  99. RONCHI C, Bernardi J, Mura M, Stefanello M, et al
    NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis.
    Cardiovasc Res. 2021;117:472-483.
    >> Share

  100. GUICHARD JB, Xiong F, Qi XY, L'Heureux N, et al
    Role of atrial arrhythmia and ventricular response in atrial fibrillation induced atrial remodelling.
    Cardiovasc Res. 2021;117:462-471.
    >> Share

    January 2020
  101. ZHANG D, Tu H, Wang C, Cao L, et al
    Inhibition of N-type calcium channels in cardiac sympathetic neurons attenuates ventricular arrhythmogenesis in heart failure.
    Cardiovasc Res. 2020 Jan 29. pii: 5717428. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016